Moderna (podjetje) (Slovenian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Moderna (podjetje)" in Slovenian language version.

refsWebsite
Global rank Slovenian rank
1st place
2nd place
4th place
8th place
2nd place
5th place
8,771st place
7,096th place
28th place
86th place
low place
9,194th place
low place
low place
210th place
469th place
49th place
97th place
220th place
894th place
407th place
3,599th place
1,248th place
703rd place
928th place
3,462nd place
433rd place
2,849th place
857th place
207th place
5th place
10th place
140th place
277th place
99th place
331st place
1,303rd place
2,448th place
2,374th place
1,034th place
92nd place
351st place
38th place
167th place
low place
low place

acs.org

cen.acs.org

biopharmadive.com

bioworld.com

bizjournals.com

  • Alspach, Kyle (22. maj 2013). »Moderna CEO Bancel joins Flagship Ventures as senior partner«. Boston Business Journal (Blog). American City Business Journals. Arhivirano iz spletišča dne 31. januarja 2014. Pridobljeno 12. marca 2020.

bloomberg.com

businessinsider.com

markets.businessinsider.com

cnbc.com

cnn.com

cnn.com

edition.cnn.com

doi.org

fortune.com

ft.com

marketwatch.com

modernatx.com

investors.modernatx.com

nejm.org

nih.gov

ncbi.nlm.nih.gov

pubmed.ncbi.nlm.nih.gov

npr.org

reuters.com

sciencemag.org

statnews.com

theconversation.com

web.archive.org

worldcat.org

  • Jackson, Lisa A.; Anderson, Evan J.; Rouphael, Nadine G.; Roberts, Paul C.; Makhene, Mamodikoe; Coler, Rhea N.; McCullough, Michele P.; Chappell, James D.; Denison, Mark R.; Stevens, Laura J.; Pruijssers, Andrea J. (14. julij 2020). »An mRNA Vaccine against SARS-CoV-2 — Preliminary Report«. New England Journal of Medicine. 0 (20): 1920–1931. doi:10.1056/NEJMoa2022483. ISSN 0028-4793. PMC 7377258. PMID 32663912. At the 100-microgram dose, the one Moderna is advancing into larger trials, all 15 patients experienced side effects, including fatigue, chills, headache, muscle pain, and pain at the site of injection. All side effects were considered mild or moderate. A higher, 250-microgram dose led to more serious reactions and has been set aside. Although no side effects were severe — meaning that they required hospitalization — they were unpleasant, as was made clear when one volunteer in the study, Ian Haydon, went public with his experience taking the 250-microgram dose.

yahoo.com

finance.yahoo.com